|
Status |
Public on Jan 01, 2022 |
Title |
TG.973: Lmo2 transgenic sample rep 2 |
Sample type |
RNA |
|
|
Source name |
Mouse thymus
|
Organism |
Mus musculus |
Characteristics |
strain: C57BL/6 tissue: Thymus
|
Extracted molecule |
total RNA |
Extraction protocol |
RNA was prepared using the RNeasy Mini Kit (Qiagen).Approximately 300 ng of total RNA was labelled and hybridised to Illumina MouseWG-6 v2.0 Expression BeadChips (Illumina) according to Illumina standard protocols.
|
Label |
Cy3
|
Label protocol |
Standard Illumina labelling protocol
|
|
|
Hybridization protocol |
Standard Illumina hybridization protocol
|
Scan protocol |
Standard Illumina scanning protocol
|
Data processing |
Raw intensity values were background corrected and normalized by the neqc method. Probes were filtered as ‘not expressed’ if they failed to achieve a BeadStudio detection P value of 0.05 on at least one array. Manufacturer probe annotation was used. Linear models were fitted to genes using Bioconductor R package limma. Differences in expression were assessed with empirical Bayes moderated t-statistics. Genes were considered to have different expression if they achieved a false-discovery rate of less than 0.05 and also a fold change greater than 1.5 folds.
|
|
|
Submission date |
Jan 25, 2019 |
Last update date |
Jan 01, 2022 |
Contact name |
Wei Shi |
E-mail(s) |
Wei.Shi@onjcri.org.au
|
Organization name |
Olivia Newton-John Cancer Research Institute
|
Street address |
145 Studley Road
|
City |
Heidelberg |
State/province |
Victoria |
ZIP/Postal code |
3084 |
Country |
Australia |
|
|
Platform ID |
GPL6887 |
Series (1) |
GSE125674 |
Lmo2 is dispensable for maintenance of most Lmo2-induced murine T-cell leukemias |
|